-
Alkalinization of the tumor microenvironment: are there prospects as a therapeutic objective?
DOI 10.31917/2303143
A.A. Bogdanov, An.A. Bogdanov, V.M. Moiseyenko
-
Vitamin C: is there a place in anticancer treatment?
DOI 10.31917/2303133
I.A. Gerk, V.M. Moiseenko
-
Iron metabolIsm and ferroptosIs as a therapeutIc target
DOI 10.31917/2303127
V.A. Chubenko
-
Multifactorial analysis of the dependence of prescribed diagnostic test systems and purchased targeted drugs on the example of lung adenocarcinoma in St.P.
DOI 10.31917/2302109
D.D. Zelikova, D.S. Yurochkin, S.E. Erdni-Garyaev, A.A. Leshkevich, Z.M. Golant, D.A. Chagin, N.M. Volkov, F.V. Moiseenko, V.M. Moiseenko
-
Possibilities of intraluminal photodynamic therapy in oncology (review)
DOI 10.31917/2302100
A.E. Akkalaeva, V.V. Klimenko, A.A. Avanesyan, V.V. Egorenkov, A.A. Bogdanov, V.M. Moiseyenko
-
The emerging field of checkpoint inhibitors
DOI 10.31917/2302093
V.A. Chubenko
-
Biomarkers predicting the effect of immunotherapy: what you need to know in practice?
DOI 10.31917/2302081
A.M. Konstantinova
-
What should we consider besides immune checkpoint drugs on the way to improvement of the efficacy?
DOI 10.31917/2302072
F.V. Moiseenko
-
Immunologic aspects of tumor biology
DOI 10.31917/2302063
N.M. Volkov
-
The most important results of clinical trials for breast cancer systemic therapy in 2021
DOI 10.31917/2301009
S.A. Tjulandin, М.В. Stenina, М.А. Frolova
-
Advances in fundamental oncology: the year 2021 update
DOI 10.31917/2301001
E.N. Imyanitov
-
Assessment of the quality of life of breast cancer patients after various types of surgical interventions
DOI 10.31917/2204298
М.А. Monogarova, Е.М. Bit-Sava, М.G. Kurbanova, А.О. Damenia, V.M. Moiseenko
-
Possibilities of intraoperative radiation therapy in the treatment of breast cancer patients
DOI 10.31917/2204291
Е.М. Bit-Sava, L.A. Gor, S.B. Bakhovadinova, М.А. Monogarova, М.G. Kurbanova, А.О. Damenia, А.М. Khabicheva, Т.S. Dzhukaeva, К.В. Mikhail, А.S. Zhurov, V.M. Moiseenko
-
The role of stereotaxic body radiotherapy (sbrt) in the treatment of patients with distant metastases
DOI 10.31917/2204282
N.V. Dengina
-
What is the role of radiotherapy for management of soft tissue and bone sarconas?
DOI 10.31917/2204267
T.M. Sharabura
-
Operation or systemic therapy in case of resectable metastases ?
DOI 10.31917/2204255
E.V. Levchenko
-
Neoadjuvant anti PD-1 / PD-L1 immune checkpoint inhibitors in locall y advanced gastric cancer with microsatellite insta bility
DOI 10.31917/2204244
A.Y. Navmatulya, V.A. Chubenko, S.A. Savchuk, F.R. Almukhametova, P.Y. Tsuprun, A.I. Kuznetsov, G.S. Inusilaev, V.A. Heinstein, K.V. Shelekhova, Е.М. Zykov, B.I. Miroshnikov, V.M. Moiseenko
-
Choosing the stage of treatment in patients with advanced forms of ovarian cancer
DOI 10.31917/2204229
V.V. Saevets, E.A. Ulrich, D.M. Rostovcev, A.Yu. Shamanova, А.A. Mukhin, S.I. Samodurov, А.V. Taratonov, Е.S. Glazyrina
-
Therapeutic targets of the tumor metabolism
DOI 10.31917/2203183
V.A. Chubenko
-
Acid-base balance in the regulation of tumor growth: value for the clinicians
DOI 10.31917/2203193
A.A. Bogdanov, An.A. Bogdanov